WHO ICTRP trial
Comparison of the effect of Olanzapine and Pregabalin after joint surgery in…
CTRI/2022/05/042766 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/05/042766 |
|---|---|
| Public title | Comparison of the effect of Olanzapine and Pregabalin after joint surgery in controlling nausea and vomiting. |
| Scientific title | Randomized, double- blind, placebo control, multi-arm, clinical trial to evaluate safety and efficacy of pre-emptive olanzapine v/s pregabalin in the management of postoperative nausea and vomiting in the patients of Arthroplasty surgery. |
| Primary sponsor | All India Institute of medical sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: M150- Primary generalized (osteo)arthritis |
| Interventions | Intervention1: 5 mg Olanzapine: Single oral dose of the Drug to be administered one hour before arthroplasty and outcomes analyzed at specific time points. Control Intervention1: 75 mg Pregabalin: Single oral dose of the Drug to be given… |
| Registration date | May 24, 2022 |
| Target size | 90 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: